Related Experiment Videos
Postoperative neuroleptic malignant syndrome
1Anaesthetic Department, North Staffordshire Royal Infirmary, Hartshill, Stoke-on-Trent.
Anaesthesia
|March 1, 1995
Summary
Neuroleptic malignant syndrome (NMS) occurred in a child after medication. Prompt treatment with dantrolene sodium and forced alkaline diuresis led to complete recovery, highlighting effective NMS management strategies.
Area of Science:
- Pediatric Neurology
- Clinical Toxicology
- Pharmacology
Background:
- Neuroleptic Malignant Syndrome (NMS) is a rare but life-threatening reaction to antipsychotic medications.
- Previous healthy pediatric patients are susceptible to NMS.
- Hyponatremia can be a potential precipitating factor in NMS development.
Observation:
- A previously healthy 6-year-old child developed NMS.
- The child had been administered droperidol and metoclopramide.
- Hyponatremia was suspected as a contributing factor.
Findings:
- The patient presented with classic symptoms of NMS.
- Treatment involved dantrolene sodium and forced alkaline diuresis.
- The child experienced a full recovery.
Implications:
- This case highlights the importance of recognizing NMS in pediatric patients.
- Early and aggressive treatment is crucial for favorable outcomes in NMS.
- Understanding potential precipitating factors like hyponatremia can aid in prevention and management.